{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:56:53Z","timestamp":1776254213470,"version":"3.50.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04224-3","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:34:04Z","timestamp":1772955244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing the LncRNA CCAT2 role in gastric cancer: from molecular insights to clinical implications"],"prefix":"10.1186","volume":"26","author":[{"given":"Amin","family":"Behzadnia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Ghorbani","family":"Vanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Ghorbaninezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ghadyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahfam","family":"Edrisian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Hedayatian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Safarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"issue":"2","key":"4224_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, et al. Global cancer statistics, 2012. Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"Cancer J Clin"},{"issue":"6","key":"4224_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"1","key":"4224_CR3","first-page":"26","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny. 2019;14(1):26\u201338.","journal-title":"Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny"},{"issue":"2","key":"4224_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer M, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487\u201390.","journal-title":"Int J Cancer"},{"issue":"1","key":"4224_CR5","first-page":"1","volume":"3","author":"JA Ajani","year":"2017","unstructured":"Ajani JA, et al. Gastric adenocarcinoma. Nat Reviews Disease Primers. 2017;3(1):1\u201319.","journal-title":"Nat Reviews Disease Primers"},{"key":"4224_CR6","doi-asserted-by":"publisher","unstructured":"Thrumurthy SG et al. The diagnosis and management of gastric cancer. BMJ, 2013;4:347. https:\/\/doi.org\/10.1136\/bmj.f6367.","DOI":"10.1136\/bmj.f6367"},{"issue":"4","key":"4224_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452\u201363.","journal-title":"Cancer Cell"},{"key":"4224_CR8","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S227831","author":"J Ding","year":"2020","unstructured":"Ding J, et al. LncRNA CCAT2 enhanced resistance of glioma cells against chemodrugs by disturbing the normal function of miR-424. Onco Targets Ther. 2020. https:\/\/doi.org\/10.2147\/OTT.S227831.","journal-title":"Onco Targets Ther"},{"key":"4224_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fonc.2018.00169","volume":"8","author":"J Clymer","year":"2018","unstructured":"Clymer J, Kieran MW. The integration of biology into the treatment of diffuse intrinsic pontine glioma: a review of the North American clinical trial perspective. Front Oncol. 2018;8:169.","journal-title":"Front Oncol"},{"issue":"10","key":"4224_CR10","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.18632\/oncotarget.1292","volume":"4","author":"RS Redis","year":"2013","unstructured":"Redis RS, et al. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013;4(10):1748\u201362.","journal-title":"Oncotarget"},{"issue":"11","key":"4224_CR11","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/ijc.35365","volume":"156","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, et al. DCLK1 in Gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target. Int J Cancer. 2025;156(11):2068\u201386.","journal-title":"Int J Cancer"},{"issue":"1","key":"4224_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10238-025-01957-9","volume":"26","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, et al. A symphony of signals: the intricate role of LncRNAs in dermatological disorders. Clin Exp Med. 2025;26(1):28.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4224_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-025-01711-1","volume":"25","author":"A Ghorbani vanan","year":"2025","unstructured":"Ghorbani vanan A, et al. Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis. Clin Experimental Med. 2025;25(1):173.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"4224_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12935-025-04017-0","volume":"25","author":"F Ghorbaninezhad","year":"2025","unstructured":"Ghorbaninezhad F, et al. Long non-coding rnas: key orchestrators of macrophage polarization in breast cancer. Cancer Cell Int. 2025;25(1):372.","journal-title":"Cancer Cell Int"},{"key":"4224_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom15111564","author":"S Tahmasebi","year":"2025","unstructured":"Tahmasebi S, et al. LncRNA-mediated miR-145 sponging drives FN1 and CCND1 expression: prognostic and therapeutic targets in NSCLC. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15111564.","journal-title":"Biomolecules"},{"issue":"3","key":"4224_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1536\/ihj.18-237","volume":"60","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. D-dimer to predict the clinical outcomes in patients with mechanical heart valve replacement during oral anticoagulation therapy. Int Heart J. 2019;60(3):631\u20136.","journal-title":"Int Heart J"},{"key":"4224_CR17","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1007\/s13277-015-3220-x","volume":"36","author":"J Wang","year":"2015","unstructured":"Wang J, et al. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Tumor Biology. 2015;36:5523\u20138.","journal-title":"Tumor Biology"},{"issue":"4","key":"4224_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.molcel.2016.01.015","volume":"61","author":"RS Redis","year":"2016","unstructured":"Redis RS, et al. Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell. 2016;61(4):520\u201334.","journal-title":"Mol Cell"},{"issue":"4","key":"4224_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.23736\/S0026-4806.17.04703-6","volume":"108","author":"S-W Wu","year":"2017","unstructured":"Wu S-W, et al. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion. Minerva Med. 2017;108(4):317\u201323.","journal-title":"Minerva Med"},{"key":"4224_CR20","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1007\/s13277-016-5348-8","volume":"37","author":"X Li","year":"2016","unstructured":"Li X, et al. Long non-coding RNA UCA1 enhances Tamoxifen resistance in breast cancer cells through a miR-18a-HIF1\u03b1 feedback regulatory loop. Tumor Biology. 2016;37:14733\u201343.","journal-title":"Tumor Biology"},{"issue":"3","key":"4224_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/cancers6031441","volume":"6","author":"T Matsuoka","year":"2014","unstructured":"Matsuoka T, Yashiro M. The role of PI3K\/Akt\/mTOR signaling in gastric carcinoma. Cancers. 2014;6(3):1441\u201363.","journal-title":"Cancers"},{"issue":"11","key":"4224_CR22","first-page":"2651","volume":"6","author":"Y-J Wang","year":"2016","unstructured":"Wang Y-J, et al. Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2. Am J Cancer Res. 2016;6(11):2651.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4224_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12935-021-02013-8","volume":"21","author":"J He","year":"2021","unstructured":"He J, et al. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int. 2021;21(1):313.","journal-title":"Cancer Cell Int"},{"issue":"7333","key":"4224_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature09677","volume":"470","author":"Z Ding","year":"2011","unstructured":"Ding Z, et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature. 2011;470(7333):269\u201373.","journal-title":"Nature"},{"issue":"3","key":"4224_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3748\/wjg.v12.i3.363","volume":"12","author":"H-C Li","year":"2006","unstructured":"Li H-C, et al. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterology: WJG. 2006;12(3):363.","journal-title":"World J Gastroenterology: WJG"},{"issue":"18","key":"4224_CR26","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.3390\/ijms22189804","volume":"22","author":"P Bule","year":"2021","unstructured":"Bule P, et al. Chemokine-directed tumor microenvironment modulation in cancer immunotherapy. Int J Mol Sci. 2021;22(18):9804.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4224_CR27","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1158\/0008-5472.CAN-07-6517","volume":"68","author":"K Ganesan","year":"2008","unstructured":"Ganesan K, et al. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel \u03b2-catenin\/TCF target gene. Cancer Res. 2008;68(11):4277\u201386.","journal-title":"Cancer Res"},{"key":"4224_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.biopha.2016.05.017","volume":"82","author":"S Chen","year":"2016","unstructured":"Chen S, et al. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Biomed Pharmacother. 2016;82:583\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4224_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","volume":"21","author":"SN Lone","year":"2022","unstructured":"Lone SN, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022;21(1):79.","journal-title":"Mol Cancer"},{"key":"4224_CR30","doi-asserted-by":"crossref","unstructured":"Methods in Medicine. In: Mathematical, editor. Retracted: the analysis of potential diagnostic and therapeutic targets for the occurrence and development of gastric cancer based on bioinformatics. Wiley Online Library; 2023.","DOI":"10.1155\/2023\/9802153"},{"issue":"9","key":"4224_CR31","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien T, et al. The GENCODE v7 catalog of human long noncoding rnas: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775\u201389.","journal-title":"Genome Res"},{"issue":"1","key":"4224_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81(1):145\u201366.","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"4224_CR33","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1101\/gr.152942.112","volume":"23","author":"H Ling","year":"2013","unstructured":"Ling H, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446\u201361.","journal-title":"Genome Res"},{"issue":"7","key":"4224_CR34","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.0906067107","volume":"107","author":"J Sotelo","year":"2010","unstructured":"Sotelo J, et al. Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci. 2010;107(7):3001\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"4224_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-04086-1","author":"M Fathollahzadeh","year":"2025","unstructured":"Fathollahzadeh M, et al. The CCAT2 enigma: pioneering insights into colorectal cancer pathophysiology and therapeutic innovation. Cancer Cell Int. 2025. https:\/\/doi.org\/10.1186\/s12935-025-04086-1.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4224_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10238-025-01730-y","volume":"25","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, et al. CCAT2 role in Gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies. Clin Experimental Med. 2025;25(1):197.","journal-title":"Clin Experimental Med"},{"issue":"22","key":"4224_CR37","doi-asserted-by":"publisher","first-page":"12491","DOI":"10.3390\/ijms222212491","volume":"22","author":"R Pirlog","year":"2021","unstructured":"Pirlog R, et al. The roles of the colon cancer associated transcript 2 (CCAT2) long Non-Coding RNA in cancer: A comprehensive characterization of the tumorigenic and molecular functions. Int J Mol Sci. 2021;22(22):12491.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4224_CR38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904\u201314.","journal-title":"Mol Cell"},{"issue":"10251","key":"4224_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"5992","key":"4224_CR40","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.1192002","volume":"329","author":"M-C Tsai","year":"2010","unstructured":"Tsai M-C, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689\u201393.","journal-title":"Science"},{"issue":"7330","key":"4224_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343\u20139.","journal-title":"Nature"},{"issue":"2","key":"4224_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","volume":"147","author":"M Cesana","year":"2011","unstructured":"Cesana M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358\u201369.","journal-title":"Cell"},{"issue":"3","key":"4224_CR43","first-page":"3369","volume":"15","author":"B Wang","year":"2018","unstructured":"Wang B, et al. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/\u03b2-catenin pathway in epithelial ovarian carcinoma cells. Oncol Lett. 2018;15(3):3369\u201375.","journal-title":"Oncol Lett"},{"issue":"3","key":"4224_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"issue":"17","key":"4224_CR45","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1007\/s00432-023-05382-x","volume":"149","author":"T Liang","year":"2023","unstructured":"Liang T, et al. Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes. J Cancer Res Clin Oncol. 2023;149(17):16043\u201353.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"suppl1","key":"4224_CR46","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","volume":"15","author":"JS Mattick","year":"2006","unstructured":"Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(suppl1):R17\u201329.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"4224_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"1","key":"4224_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","volume":"157","author":"DR Green","year":"2014","unstructured":"Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014;157(1):65\u201375.","journal-title":"Cell"},{"issue":"6","key":"4224_CR49","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/\u03b2-catenin signaling and disease. Cell. 2012;149(6):1192\u2013205.","journal-title":"Cell"},{"key":"4224_CR50","doi-asserted-by":"publisher","first-page":"681053","DOI":"10.3389\/fgene.2021.681053","volume":"12","author":"A Sharma","year":"2021","unstructured":"Sharma A, Mir R, Galande S. Epigenetic regulation of the Wnt\/\u03b2-catenin signaling pathway in cancer. Front Genet. 2021;12:681053.","journal-title":"Front Genet"},{"issue":"7035","key":"4224_CR51","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434(7035):843\u201350.","journal-title":"Nature"},{"issue":"5","key":"4224_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","volume":"343","author":"R Medzhitov","year":"2000","unstructured":"Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343(5):338\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"4224_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/abbs\/gms108","volume":"45","author":"X Li","year":"2013","unstructured":"Li X. SIRT1 and energy metabolism. Acta Biochim Biophys Sin. 2013;45(1):51\u201360.","journal-title":"Acta Biochim Biophys Sin"},{"key":"4224_CR54","doi-asserted-by":"publisher","first-page":"624112","DOI":"10.3389\/fendo.2021.624112","volume":"12","author":"M Hernandez-Quiles","year":"2021","unstructured":"Hernandez-Quiles M, Broekema MF, Kalkhoven E. PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action. Front Endocrinol. 2021;12:624112.","journal-title":"Front Endocrinol"},{"issue":"8","key":"4224_CR55","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.3390\/cimb46080522","volume":"46","author":"P Patyal","year":"2024","unstructured":"Patyal P, et al. The role of Sirtuin-1 isoforms in regulating mitochondrial function. Curr Issues Mol Biol. 2024;46(8):8835\u201351.","journal-title":"Curr Issues Mol Biol"},{"issue":"7364","key":"4224_CR56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nature10398","volume":"477","author":"M Guttman","year":"2011","unstructured":"Guttman M, et al. LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477(7364):295\u2013300.","journal-title":"Nature"},{"issue":"4","key":"4224_CR57","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629\u201341.","journal-title":"Cell"},{"issue":"6","key":"4224_CR58","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4161\/rna.20481","volume":"9","author":"T Gutschner","year":"2012","unstructured":"Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703\u201319.","journal-title":"RNA Biol"},{"key":"4224_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-04091-4","author":"S Tahmasebi","year":"2025","unstructured":"Tahmasebi S, et al. Harnessing miR-145 in NSCLC: mechanistic roles, diagnostic-prognostic utility, and therapeutic potential. Cancer Cell Int. 2025. https:\/\/doi.org\/10.1186\/s12935-025-04091-4.","journal-title":"Cancer Cell Int"},{"key":"4224_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042417","author":"AC Ward","year":"2024","unstructured":"Ward AC. Immune factors, immune cells and inflammatory diseases. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25042417.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4224_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47\u201362.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"4224_CR62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nsmb.2480","volume":"20","author":"TR Mercer","year":"2013","unstructured":"Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300\u20137.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"4224_CR63","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1038\/s41598-022-11090-2","volume":"12","author":"H Selven","year":"2022","unstructured":"Selven H, et al. High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer. Sci Rep. 2022;12(1):7080.","journal-title":"Sci Rep"},{"issue":"8","key":"4224_CR64","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/ng.406","volume":"41","author":"S Tuupanen","year":"2009","unstructured":"Tuupanen S, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet. 2009;41(8):885\u201390.","journal-title":"Nat Genet"},{"key":"4224_CR65","first-page":"2657","volume":"8","author":"Y Cai","year":"2015","unstructured":"Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 2015;8:2657\u201364.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"4224_CR66","doi-asserted-by":"publisher","first-page":"300060521101993","DOI":"10.1177\/03000605211019938","volume":"49","author":"C Yang","year":"2021","unstructured":"Yang C, et al. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the \u03b2-catenin\/WISP1 signaling pathway. J Int Med Res. 2021;49(5):3000605211019938.","journal-title":"J Int Med Res"},{"issue":"4","key":"4224_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4331\/wjbc.v6.i4.290","volume":"6","author":"S Rennoll","year":"2015","unstructured":"Rennoll S, Yochum G. Regulation of MYC gene expression by aberrant Wnt\/\u03b2-catenin signaling in colorectal cancer. World J Biol Chem. 2015;6(4):290\u2013300.","journal-title":"World J Biol Chem"},{"issue":"6","key":"4224_CR68","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/MCB.01384-09","volume":"30","author":"JB Wright","year":"2010","unstructured":"Wright JB, Brown SJ, Cole MD. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol. 2010;30(6):1411\u201320.","journal-title":"Mol Cell Biol"},{"issue":"43","key":"4224_CR69","doi-asserted-by":"publisher","first-page":"75664","DOI":"10.18632\/oncotarget.18161","volume":"8","author":"D Wang","year":"2017","unstructured":"Wang D, et al. Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis. Oncotarget. 2017;8(43):75664\u201374.","journal-title":"Oncotarget"},{"issue":"1","key":"4224_CR70","first-page":"779","volume":"8","author":"CY Wang","year":"2015","unstructured":"Wang CY, et al. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015;8(1):779\u201385.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"4224_CR71","first-page":"13261","volume":"8","author":"X Chen","year":"2015","unstructured":"Chen X, Liu L, Zhu W. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients. Int J Clin Exp Pathol. 2015;8(10):13261\u20136.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"4224_CR72","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1007\/s13277-015-3220-x","volume":"36","author":"J Wang","year":"2015","unstructured":"Wang J, et al. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Tumour Biol. 2015;36(7):5523\u20138.","journal-title":"Tumour Biol"},{"issue":"1","key":"4224_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13000-016-0499-x","volume":"11","author":"S Huang","year":"2016","unstructured":"Huang S, et al. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11(1):49.","journal-title":"Diagn Pathol"},{"issue":"6","key":"4224_CR74","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1007\/s13277-014-1700-z","volume":"35","author":"M Qiu","year":"2014","unstructured":"Qiu M, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 2014;35(6):5375\u201380.","journal-title":"Tumour Biol"},{"key":"4224_CR75","doi-asserted-by":"publisher","first-page":"875","DOI":"10.12659\/MSM.897754","volume":"22","author":"L Wu","year":"2016","unstructured":"Wu L, et al. Roles of long Non-Coding RNA CCAT2 in cervical cancer cell growth and apoptosis. Med Sci Monit. 2016;22:875\u20139.","journal-title":"Med Sci Monit"},{"issue":"1","key":"4224_CR76","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3892\/ol.2016.4580","volume":"12","author":"N Zhou","year":"2016","unstructured":"Zhou N, et al. Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis. Oncol Lett. 2016;12(1):132\u20138.","journal-title":"Oncol Lett"},{"issue":"11","key":"4224_CR77","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00432-016-2183-7","volume":"142","author":"W Sun","year":"2016","unstructured":"Sun W, et al. Roles of long noncoding RNAs in gastric cancer and their clinical applications. J Cancer Res Clin Oncol. 2016;142(11):2231\u20137.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4224_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12342","author":"Y Xin","year":"2017","unstructured":"Xin Y, et al. CCAT2: a novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017. https:\/\/doi.org\/10.1111\/cpr.12342.","journal-title":"Cell Prolif"},{"issue":"6","key":"4224_CR79","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s13402-023-00835-4","volume":"46","author":"H Deng","year":"2023","unstructured":"Deng H, et al. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cell Oncol (Dordr). 2023;46(6):1675\u201390.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"4224_CR80","first-page":"3127","volume":"15","author":"ZY Yu","year":"2018","unstructured":"Yu ZY, et al. Effect of Silencing colon cancer-associated transcript 2 on the proliferation, apoptosis and autophagy of gastric cancer BGC-823 cells. Oncol Lett. 2018;15(3):3127\u201332.","journal-title":"Oncol Lett"},{"key":"4224_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/OTT.S220302","volume":"13","author":"S Lin","year":"2020","unstructured":"Lin S, et al. Silencing of long Non-Coding RNA colon cancer-Associated transcript 2 inhibits the growth and metastasis of gastric cancer through blocking mTOR signaling. Onco Targets Ther. 2020;13:337\u201349.","journal-title":"Onco Targets Ther"},{"key":"4224_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212491","author":"R Pirlog","year":"2021","unstructured":"Pirlog R, et al. The roles of the colon cancer associated transcript 2 (CCAT2) long non-coding RNA in cancer: a comprehensive characterization of the tumorigenic and molecular functions. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222212491.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4224_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/onc.2013.547","volume":"34","author":"H Hayashi","year":"2015","unstructured":"Hayashi H, et al. The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer. Oncogene. 2015;34(2):199\u2013208.","journal-title":"Oncogene"},{"key":"4224_CR84","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145\u201366.","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"4224_CR85","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4274\/tjps.galenos.2021.03502","volume":"19","author":"N Jabbari","year":"2022","unstructured":"Jabbari N, et al. Gemini Curcumin suppresses gastric cancer AGS cell proliferation through modulation of LncRNA CCAT2 and c-Myc genes. Turk J Pharm Sci. 2022;19(3):239\u201345.","journal-title":"Turk J Pharm Sci"},{"issue":"11","key":"4224_CR86","first-page":"2651","volume":"6","author":"YJ Wang","year":"2016","unstructured":"Wang YJ, et al. Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2. Am J Cancer Res. 2016;6(11):2651\u201360.","journal-title":"Am J Cancer Res"},{"key":"4224_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189804","author":"P Bule","year":"2021","unstructured":"Bule P, et al. Chemokine-directed tumor microenvironment modulation in cancer immunotherapy. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22189804.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4224_CR88","doi-asserted-by":"publisher","first-page":"213","DOI":"10.7150\/thno.16044","volume":"7","author":"K Zhang","year":"2017","unstructured":"Zhang K, et al. Genome-Wide LncRNA microarray profiling identifies novel Circulating LncRNAs for detection of gastric cancer. Theranostics. 2017;7(1):213\u201327.","journal-title":"Theranostics"},{"issue":"17","key":"4224_CR89","doi-asserted-by":"publisher","first-page":"e70169","DOI":"10.1002\/cam4.70169","volume":"13","author":"J Tian","year":"2024","unstructured":"Tian J, et al. LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression. Cancer Med. 2024;13(17):e70169.","journal-title":"Cancer Med"},{"issue":"2","key":"4224_CR90","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3892\/or.2017.5742","volume":"38","author":"HL Lang","year":"2017","unstructured":"Lang HL, et al. Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2. Oncol Rep. 2017;38(2):785\u201398.","journal-title":"Oncol Rep"},{"issue":"1","key":"4224_CR91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41698-018-0049-y","volume":"2","author":"WJ Jeong","year":"2018","unstructured":"Jeong WJ, Ro EJ, Choi KY. Interaction between Wnt\/beta-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of beta-catenin and RAS by targeting the Wnt\/beta-catenin pathway. NPJ Precis Oncol. 2018;2(1):5.","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"4224_CR92","first-page":"706","volume":"21","author":"ZJ Wu","year":"2017","unstructured":"Wu ZJ, et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-beta signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(4):706\u201314.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4224_CR93","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.2147\/OTT.S169823","volume":"11","author":"S Gao","year":"2018","unstructured":"Gao S, et al. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Onco Targets Ther. 2018;11:4877\u201391.","journal-title":"Onco Targets Ther"},{"issue":"23","key":"4224_CR94","first-page":"12224","volume":"24","author":"W Fu","year":"2020","unstructured":"Fu W, et al. CCAT2 contributes to progression and treatment resistance of thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(23):12224\u201331.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4224_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040858","author":"C Pereira","year":"2020","unstructured":"Pereira C, et al. Expression of CD44v6-containing isoforms influences Cisplatin response in gastric cancer cells. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12040858.","journal-title":"Cancers (Basel)"},{"key":"4224_CR96","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cca.2017.03.003","volume":"468","author":"X Jing","year":"2017","unstructured":"Jing X, et al. Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis. Clin Chim Acta. 2017;468:159\u201365.","journal-title":"Clin Chim Acta"},{"key":"4224_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2017.01.016","volume":"466","author":"YH Fan","year":"2017","unstructured":"Fan YH, et al. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis. Clin Chim Acta. 2017;466:120\u20136.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"4224_CR98","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/annonc\/mdx248","volume":"28","author":"T Ozawa","year":"2017","unstructured":"Ozawa T, et al. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 \u2018gene desert\u2019, serve as important prognostic biomarkers in colorectal cancer. Ann Oncol. 2017;28(8):1882\u20138.","journal-title":"Ann Oncol"},{"issue":"6","key":"4224_CR99","first-page":"6907","volume":"14","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Oncol Lett. 2017;14(6):6907\u201314.","journal-title":"Oncol Lett"},{"issue":"4","key":"4224_CR100","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bbrc.2016.08.120","volume":"480","author":"J Zheng","year":"2016","unstructured":"Zheng J, et al. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2016;480(4):508\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"4224_CR101","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s11010-020-04042-9","volume":"476","author":"M Chen","year":"2021","unstructured":"Chen M, et al. Expression of LncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth. Mol Cell Biochem. 2021;476(4):1871\u20139.","journal-title":"Mol Cell Biochem"},{"key":"4224_CR102","doi-asserted-by":"publisher","first-page":"104628","DOI":"10.1016\/j.phrs.2020.104628","volume":"152","author":"Z Xu","year":"2020","unstructured":"Xu Z, et al. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells. Pharmacol Res. 2020;152:104628.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4224_CR103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13048-022-00950-0","volume":"15","author":"X Cao","year":"2022","unstructured":"Cao X, et al. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer. J Ovarian Res. 2022;15(1):20.","journal-title":"J Ovarian Res"},{"key":"4224_CR104","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biopha.2018.01.061","volume":"99","author":"Y Xu","year":"2018","unstructured":"Xu Y, et al. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Biomed Pharmacother. 2018;99:121\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4224_CR105","first-page":"5328","volume":"17","author":"JG Bai","year":"2018","unstructured":"Bai JG, et al. Upregulation of long non\u2013coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma. Mol Med Rep. 2018;17(4):5328\u201335.","journal-title":"Mol Med Rep"},{"key":"4224_CR106","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2147\/OTT.S127100","volume":"10","author":"Y Xu","year":"2017","unstructured":"Xu Y, et al. Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition. Onco Targets Ther. 2017;10:1191\u20138.","journal-title":"Onco Targets Ther"},{"issue":"42","key":"4224_CR107","doi-asserted-by":"publisher","first-page":"e17412","DOI":"10.1097\/MD.0000000000017412","volume":"98","author":"C Fu","year":"2019","unstructured":"Fu C, et al. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma. Med (Baltim). 2019;98(42):e17412.","journal-title":"Med (Baltim)"},{"issue":"7","key":"4224_CR108","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/jso.23888","volume":"111","author":"X Zhang","year":"2015","unstructured":"Zhang X, et al. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2015;111(7):834\u20139.","journal-title":"J Surg Oncol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04224-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:05:13Z","timestamp":1776251113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04224-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4224"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04224-3","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}